EVELO BIOSCIENCES, INC.
CIK 0001694665
Revenue (TTM)
—
Q3 Nov 2023
Net Income (TTM)
−$89.37M
+6.3% YoY
Q3 Nov 2023
EPS Diluted (TTM)
−$10.38
+43.3% YoY
Q3 Nov 2023
Gross Margin
—
Q3 Nov 2023
Operating Margin
—
Q3 Nov 2023
Net Margin
—
Q3 Nov 2023
Free Cash Flow (TTM)
−$95.92M
Q3 Nov 2023
Cash
$17.26M
Q3 Nov 2023
Total Debt
$33.95M
Q3 Nov 2023
Shares Outstanding
18.93M sh
Q3 Nov 2023
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.